SNIFF study to examine safety and efficacy of nasal insulin for treating Alzheimer’s

27 Mar 2017


Neurologists at the Rush Alzheimer's Disease Center are conducting an 18-month clinical trial testing a type of insulin delivered in a nasal spray used to treat diabetes in some patients - in the Study of Nasal Insulin to Fight Forgetfulness (SNIFF).

News Medical


Related Topics

Diabetes

Share this story